Continuous wave

World First Dual Wave RF Micro-needling System: Sylfirm X is Recognized by TOP US Aesthetic Dermatologists

Retrieved on: 
Wednesday, November 9, 2022

The Symposium invited renowned domestic aesthetic dermatologists and Top US board-certified plastic surgeons, bringing together a total of 100 aesthetic practitioners in one place.

Key Points: 
  • The Symposium invited renowned domestic aesthetic dermatologists and Top US board-certified plastic surgeons, bringing together a total of 100 aesthetic practitioners in one place.
  • The Symposium Program was composed of lectures on scientific background and the unique discovery of Sylfirm X technology.
  • Domestic skin experts in the aesthetic field exchanged their research results and shared discovered treatment solutions with SYLFIRM X.
  • Sylfirm X is the worlds first FDA-cleared Pulsed Wave (PW) and Continuous Wave (CW) Radio Frequency Micro Needling device that targets both skin laxity and pigmentation.

POET Technologies Reports Fourth Quarter 2021 Financial Results

Retrieved on: 
Wednesday, April 27, 2022

TORONTO, April 26, 2022 (GLOBE NEWSWIRE) -- POET Technologies Inc. (POET or the Company) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today reported its audited condensed consolidated financial results for the fourth quarter and full year ended December 31, 2021.

Key Points: 
  • TORONTO, April 26, 2022 (GLOBE NEWSWIRE) -- POET Technologies Inc. (POET or the Company) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today reported its audited condensed consolidated financial results for the fourth quarter and full year ended December 31, 2021.
  • The Company had debt related finance costs of $16,000 in the fourth quarter of 2021 compared to $249,000 in the fourth quarter of 2020 and $20,000 in the third quarter of 2021.
  • Impact of joint venture in the fourth quarter of 2021 was $1.0 million compared to nil in the same period of 2020 and $0.4 million in the third quarter of 2021.
  • On a non-IFRS basis, cash flow from operating activities in the fourth quarter of 2021 was ($3.2) million compared to ($2.9) million in the fourth quarter of 2020 and ($2.8) million in the third quarter of 2021.

nLIGHT, Inc. Announces New 2 micron Fiber Laser Series

Retrieved on: 
Monday, April 25, 2022

nLIGHT, Inc. (NASDAQ: LASR), a global leader in semiconductor and fiber lasers, today announced the introduction of the 2 micron fiber laser series for a diverse set of medical, industrial, scientific, aerospace and defense applications.

Key Points: 
  • nLIGHT, Inc. (NASDAQ: LASR), a global leader in semiconductor and fiber lasers, today announced the introduction of the 2 micron fiber laser series for a diverse set of medical, industrial, scientific, aerospace and defense applications.
  • The 2 micron series fiber lasers offers a unique combination of pulse energy and pulse modulation unattainable by legacy lasers, states Matthew Randall, Vice President and General Manager of nLIGHTs Semiconductor Laser Business.
  • The introduction of the 2 micron series further extends nLIGHTs leadership in high power fiber lasers.
  • See the nLIGHT 2 micron series fiber lasers, April 26 29 at the Lasers World of Photonics in Munich, Germany.

Global Quantum Cascade Lasers Market to Reach $462.2 Million by 2026

Retrieved on: 
Thursday, March 24, 2022

SAN FRANCISCO, March 24, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Quantum Cascade Lasers - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, March 24, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Quantum Cascade Lasers - Global Market Trajectory & Analytics" .
  • Amid the COVID-19 crisis, the global market for Quantum Cascade Lasers estimated at US$391.1 Million in the year 2022, is projected to reach a revised size of US$462.2 Million by 2026, growing at a CAGR of 4% over the analysis period.
  • This segment currently accounts for a 29.9% share of the global Quantum Cascade Lasers market.
  • The U.S. Market is Estimated at $220.2 Million in 2022, While China is Forecast to Reach $18.7 Million by 2026
    The Quantum Cascade Lasers market in the U.S. is estimated at US$220.2 Million in the year 2022.

POET Technologies Reports Third Quarter 2021 Financial Results

Retrieved on: 
Wednesday, November 24, 2021

TORONTO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- POET Technologies Inc. (POET or the Company) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today reported its unaudited condensed consolidated financial results for the third quarter ended September 30, 2021.

Key Points: 
  • TORONTO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- POET Technologies Inc. (POET or the Company) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today reported its unaudited condensed consolidated financial results for the third quarter ended September 30, 2021.
  • Of the finance costs recognized in the third quarter of 2021, $18,000 was non-cash compared to $141,000 during the same period in 2020 and $49,000 in the second quarter of 2021.
  • The Company recognized other income, including interest of $208,000 in the third quarter of 2021 compared to $14,000 in the same period in 2020 and $20,000 in the second quarter of 2021.
  • On a non-IFRS basis, cash flow from operating activities in the third quarter of 2021 was ($2.8) million compared to ($2.9) million in the third quarter of 2020 and ($2.6) million in the second quarter of 2021.

Retina and Glaucoma Experts Will Present Best Practices Using Iridex Technologies at a Consensus Panel and the AAO Annual Meeting

Retrieved on: 
Saturday, November 6, 2021

MOUNTAIN VIEW, Calif., Nov. 06, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announces that an international consensus panel of ten glaucoma experts will discuss MicroPulse Transscleral Laser Therapy and their conclusions for proper dosing and patient selection on November 6 at 10:00am PT/ 1:00pm ET. In the live discussion, attendees will learn recommendations for treatment optimization and settings with the MicroPulse P3® Probe, understand the concept of fluence and the importance of sweep speed, as well as identify the clinical drivers for patient selection, outcomes, and safety.

Key Points: 
  • Nineteen laser experts, including Robert J. Noecker, MD; Brian A. Francis, MD; Sam E. Mansour, MD; and Nathan Radcliffe, MD, will be available to discuss experiences, surgical pearls and best practices.
  • To find out specific times and available experts, visit https://www.iridex.com/aao
    Two Iridex glaucoma procedures, MicroPulse Transscleral Laser Therapy and Continuous Wave Transscleral Cyclophotocoagulation, will be featured in one of AAO's Skills Transfer Labs.
  • The title of the course is "Lasers in Glaucoma," and its director will be Lisa S. Gamell, MD.
  • This course is part of the AAO program; participation requires an AAO registration.

POET Technologies Collaborates with a Leading Global Supplier of Lasers for POET’s Optical Interposer Platform

Retrieved on: 
Tuesday, November 2, 2021

In this first phase, POET will work with the Supplier on a customized version of its current flip-chippable production CW laser.

Key Points: 
  • In this first phase, POET will work with the Supplier on a customized version of its current flip-chippable production CW laser.
  • The customization to the physical design would enable the existing laser to be compatible with POETs Optical interposer platform, which enables passive, wafer-scale hybrid integration of lasers to produce high performance Optical Engines.
  • CW lasers combined with a Silicon Photonics-based modulator will be incorporated in transmit Optical Engines operating at 400G speeds and beyond.
  • In a subsequent phase, the Supplier will build and supply known good lasers for use by POET in the production of 400G Optical Engines.

Global Industry Analysts Predicts the World Quantum Cascade Lasers Market to Reach $405.5 Million by 2026

Retrieved on: 
Friday, October 22, 2021

SAN FRANCISCO, Oct. 22, 2021 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Quantum Cascade Lasers - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, Oct. 22, 2021 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Quantum Cascade Lasers - Global Market Trajectory & Analytics" .
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Quantum Cascade Lasers estimated at US$325.5 Million in the year 2020, is projected to reach a revised size of US$405.5 Million by 2026, growing at a CAGR of 3.7% over the analysis period.
  • The U.S. Market is Estimated at $100.1 Million in 2021, While China is Forecast to Reach $72.4 Million by 2026
    The Quantum Cascade Lasers market in the U.S. is estimated at US$100.1 Million in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com )is a renowned market research publisher the world`s only influencer driven market research company.

Serendia, LLC Files Patent Infringement Lawsuits against Cartessa and SHEnB Relating to Radio Frequency Microneedling Devices

Retrieved on: 
Wednesday, September 22, 2021

The lawsuits assert that the accused produce, import and sell infringing products and services throughout the U.S.

Key Points: 
  • The lawsuits assert that the accused produce, import and sell infringing products and services throughout the U.S.
  • The infringing products include Vivace and Virtue RF, which are radio frequency ("RF") microneedling devices manufactured and/or distributed by the accused for treatment of dermatological issues.
  • Sylfirm X is the world's first and only FDA cleared Pulsed Wave and Continuous Wave RF microneedling device.
  • The lawsuits accuse infringement of four U.S. patents: 9,320,536 (titled "Method, System, and Apparatus for Dermatological Treatment.

POET Technologies Teams-up with SiLUX Technologies to Demonstrate its 400G Optical Engine during China International Optoelectronics Exhibition

Retrieved on: 
Thursday, September 9, 2021

The 400G CWDM4 optical engine has monolithically integrated optical multiplexers, waveguides and coupling structures.

Key Points: 
  • The 400G CWDM4 optical engine has monolithically integrated optical multiplexers, waveguides and coupling structures.
  • SiluxTek's Silicon Photonic Modulator PIC is being used to complete the 400G engine, providing high-speed modulation of light for data transmission.
  • POETs Optical Interposer is designed with a proprietary optical interconnect layer deposited onto a standard 200mm (8 inch) silicon wafer.
  • In subsequent versions of the 400G Optical Engine, SiluxTeks Silicon Photonic modulator will be passively flip-chipped onto the optical interposer, providing a low cost, scalable, high performance 400G solution.